When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BBIO - Alexion inks deal for ATTR investigational medicine in Japan
BridgeBio Pharma Inc.
Alexion Pharmaceuticals (NASDAQ:ALXN) and BridgeBio Pharma's (NASDAQ:BBIO) subsidiary Eidos Therapeutics (NASDAQ:EIDX) have announced an agreement that grants Alexion an exclusive license to develop and commercialize AG10 in Japan.
More news on: Alexion Pharmaceuticals, Inc., Eidos Therapeutics, Inc., BridgeBio Pharma, Inc., Healthcare stocks news,